The global eubiotics market is expected to reach USD 9.4 billion by 2025, according
to a new report by Grand View Research, Inc. Growing meat consumption coupled
with rising awareness regarding meat quality is expected to drive global
eubiotics market growth.
Eubiotics influence the gut microflora and
confer health benefits on the host. They maintain a correct balance of the
microbial activity in the gastrointestinal tract of animals. This results in
benefits such as enhanced nutrient absorption, better immunity and increase in
overall performance. Such advantages are expected to drive the market growth
over the forecast period.
Probiotics emerged as the largest product
segment in 2016 and was valued at USD 2.5 billion in 2016. Broad product
portfolio, rising awareness and efficacy in animal feed usage are the major
attributed reasons for this scenario
Gut health dominated the application
segment in 2016 and is expected to grow at an anticipated CAGR of 8.2% from
2017 to 2025. Eubiotics efficiency in treating gut related disorders and search
for viable alternative to antibiotics are expected to drive market growth.
Immunity is expected to observe the fastest growth among applications.
Fodder and water shortage, decreasing
grazing lands has put pressure on livestock farmers to optimize feed
utilization. Eubiotics cater to this demand by enhancing feed utilization, and
increasing yield in comparatively less feed. Such trends are expected to fuel
market growth over the next eight years.
To request a sample copy
or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/eubiotics-market
http://www.grandviewresearch.com/industry-analysis/eubiotics-market
Further key findings from the report suggest:
· The global eubiotics market worth is
expected to be 9.4 billion and is expected to grow at a CAGR of 8.2% from 2017
to 2025
· Solid form dominated the form segment and
was valued at USD 2.9 billion in 2016. Liquid form is expected to grow at an
anticipated CAGR of 8.0% over the next eight years
· The U.S. market worth for eubiotics used in
poultry end use was USD 264.6 million in 2016. Rising demand for poultry meat
and eggs, demand for high quality meat and concerns over antibiotics have
resulted in an increased preference for usage in poultry end use.
· Asia Pacific is expected to witness the
highest growth rate over the next eight years. Strong demand from countries
such as China and India, growing meat consumption in the region and rising
concerns over antibiotics usage is expected to fuel market growth
· Companies are focusing on developing
regions such as Asia Pacific to increase market share. Key industry
participants include Calpis, DSM, Novus, Lesaffre Group, Lallemand Inc., and
E.I. Du Pont De Nemours and Company.
Grand View Research has segmented the
global eubiotics market on the basis of product, form, application, end use and
region:
Product Outlook (Revenue, USD Million, 2014
- 2025)
·
Probiotics
·
Prebiotics
·
Organic Acids
·
Essential Oils
Form Outlook (Revenue, USD Million, 2014 -
2025)
·
Liquid Form
·
Solid Form
Application Outlook (Revenue, USD Million,
2014 - 2025)
·
Gut health
·
Immunity
·
Yield
·
Others
End-use Outlook (Revenue, USD Million, 2014
- 2025)
·
Cattle feed
·
Dairy
·
Meat
·
Poultry
·
Swine
·
Aquatic
·
Others
Regional Outlook (Revenue, USD Million,
2014 - 2025)
·
North America
o
U.S
·
Europe
o
Germany
o
UK
o
France
o
Spain
·
Asia Pacific
o
China
o
India
o
Japan
·
Central & South America
·
Middle East & Africa
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
